Conference Reports for NATAP

The International Liver Congress™ EASL - European Association for the Study of the Liver 2019 April 10-14 Vienna Austria Back

Short term RNA interference (RNAi) therapy in chronic hepatitis B (CHB) using JNJ-3989 brings majority of patients to HBsAg <100 IU/ml threshold       Reported by Jules Levin EASL 2019 April 10-14 Vienna